Clinical Trial Update: Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome [NA]

View source ↗

Summary

A pilot clinical trial evaluating RGn550 for safety and performance in athletes with acute concussion syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Concussion

Drugs mentioned

• RGn550

Snippet

Sponsor: REGEnLIFE SAS | Conditions: Acute Concussion Syndrome | NA | Status: COMPLETED | Results posted: 2024-12-05